Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Item

http://www.wikidata.org/entity/Q42660774

Q42660774

about

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.Clonal architecture of del(5q) myelodysplastic syndromes: aberrant CD5 or CD7 expression within the myeloid progenitor compartment defines a subset with high clonal burden Normal variation of bone marrow B-cell precursors according to age - reference ranges for studies in myelodysplastic syndromes in Brazil.

P2860

Q26742112-48F42B0F-E80D-4FD0-B3BA-EBBF9FFBB691 Q38540015-7D8216A4-941C-48D9-8801-13650FF2DB40 Q38908087-66A4B8C5-1F3C-4A52-8518-3FFA735E3B18 Q39361802-A40D05A2-8E13-460D-8F4A-2281A806421B Q42550078-80A4B45C-1ED0-4BDB-99BF-DA02830EB66F Q48178188-EAE742AB-9AE7-4713-B6A4-680E037F549A

P2860

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Item

http://www.wikidata.org/entity/Q42660774

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Multicentric study underlining ...... /myeloproliferative neoplasms.

@en

Multicentric study underlining ...... /myeloproliferative neoplasms.

@nl

type

Item

label

Multicentric study underlining ...... /myeloproliferative neoplasms.

@en

Multicentric study underlining ...... /myeloproliferative neoplasms.

@nl

prefLabel

Multicentric study underlining ...... /myeloproliferative neoplasms.

@en

Multicentric study underlining ...... /myeloproliferative neoplasms.

@nl

P1476

Multicentric study underlining ...... c/myeloproliferative neoplasms

@en

P2093

Andréa Toma

http://www.w3.org/2001/XMLSchema#string

Camille Debord

http://www.w3.org/2001/XMLSchema#string

Cédric Rossi

http://www.w3.org/2001/XMLSchema#string

Céline Morvan

http://www.w3.org/2001/XMLSchema#string

Emmanuel Benayoun

http://www.w3.org/2001/XMLSchema#string

Estelle Guérin

http://www.w3.org/2001/XMLSchema#string

Franck Trimoreau

http://www.w3.org/2001/XMLSchema#string

Groupe Francophone des Myélodysplasies (GFM)

http://www.w3.org/2001/XMLSchema#string

Groupe d’Etude Immunologique des Leucémies (GEIL)

http://www.w3.org/2001/XMLSchema#string

Julien Guy

http://www.w3.org/2001/XMLSchema#string

P2860

Flow cytometric differential of leukocyte populations in normal bone marrow: influence of peripheral blood contamination.

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data.

Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.

Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias.

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls.

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome.

Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.

The genetic basis of myelodysplasia and its clinical relevance

TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors.

P304

472-478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2014.112755

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Jean Feuillard

Nicolas Chapuis

Valérie Bardet

Orianne Wagner-Ballon

P577

2015-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271647660

http://www.w3.org/2001/XMLSchema#string

P698

25637056

http://www.w3.org/2001/XMLSchema#string

P932

4380720

http://www.w3.org/2001/XMLSchema#string

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

about

P2860

P2860

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932